CoChat

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis

Open access
Solé, Laura, Lobo-Jarne, Teresa, Álvarez-Villanueva, Daniel, Alonso-Marañón, Josune, Guillén, Yolanda, Guix, Marta, Sangrador, Irene, Rozalén, Catalina, Vert, Anna, Barbachano, Antonio, Lop, Joan, Salido, Marta, Bellosillo, Beatriz, García-Romero, Raquel, Garrido, Marta, González, Jessica, Martínez-Iniesta, María, López-Arribillaga, Erika, Salazar, Ramón, Montagut, Clara, Torres, Ferrán, Iglesias, Mar, Celià-Terrassa, Toni, Muñoz, Alberto, Villanueva, Alberto, Bigas, Anna, Espinosa, Lluís · 2022 · Nature Communications
Cited by 60

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Current therapy against colorectal cancer (CRC) is based on DNA-damaging agents that remain ineffective in a proportion of patients. Whether and how non-curative DNA damage-based treatment affects tumor cell behavior and patient outcome is primarily unstudied. Using CRC patient-derived organoids (PDO)s, we show that sublethal doses of chemotherapy (CT) does not select previously resistant tumor populations but induces a quiescent state specifically to TP53 wildtype (WT) cancer cells, which is linked to the acquisition of a YAP1-dependent fetal phenotype. Cells displaying this phenotype exhibit high tumor-initiating and metastatic activity. Nuclear YAP1 and fetal traits are present in a proportion of tumors at diagnosis and predict poor prognosis in patients carrying TP53 WT CRC tumors. We provide data indicating the higher efficacy of CT together with YAP1 inhibitors for eradication of therapy resistant TP53 WT cancer cells. Together these results identify fetal conversion as a useful biomarker for patient prognosis and therapy prescription.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-30382-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 60

Metadata

Authors
Solé, L., Lobo-Jarne, T., Álvarez-Villanueva, D., Alonso-Marañón, J., Guillén, Y., Guix, M., Sangrador, I., Rozalén, C., Vert, A., Barbachano, A., Lop, J., Salido, M., Bellosillo, B., García-Romero, R., Garrido, M., González, J., Martínez-Iniesta, M., López-Arribillaga, E., Salazar, R., Montagut, C., Torres, F., Iglesias, M., Celià-Terrassa, T., Muñoz, A., Villanueva, A., Bigas, A., & Espinosa, L.
Venue
Nature Communications
Published
2022-05-23
Volume
13
Issue
1
Pages
2866-2866
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4281396271
Cited by
60
References
10
FWCI
5.12
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis. https://app.cochat.ai/papers/10.1038/s41467-022-30382-9
The paper
Solé, L., Lobo-Jarne, T., Álvarez-Villanueva, D., Alonso-Marañón, J., Guillén, Y., Guix, M., Sangrador, I., Rozalén, C., Vert, A., Barbachano, A., Lop, J., Salido, M., Bellosillo, B., García-Romero, R., Garrido, M., González, J., Martínez-Iniesta, M., López-Arribillaga, E., Salazar, R., . . . Espinosa, L. (2022). p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis. Nature Communications. https://doi.org/10.1038/s41467-022-30382-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.